Write your message
Volume 7, Issue 3 (May & June - Volume 07 - Issue 03 2022)                   J Obstet Gynecol Cancer Res 2022, 7(3): 200-205 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabatabaei S M, Taheri Soodejani M, Shoraka H R, Mahmoudimanesh M, Eslami S, Ghaderi A. Incidence of Breast and Cervical intraepithelial Lesions: Results of a Screening Program for Women. J Obstet Gynecol Cancer Res. 2022; 7 (3) :200-205
URL: http://jogcr.com/article-1-490-en.html
1- Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2- Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of public health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3- Vector-Borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran
4- Department of Biostatistics and Epidemiology, School of Health, Kerman University of Medical Sciences, Kerman, Iran
5- Department of Medical Informatics, University of Amsterdam, Amsterdam, Netherlands
6- Department of Fighting against Disease, Najaf Abad Health Services Center, Isfahan University of Medical Sciences, Najaf Abad, Iran , azimehghaderi@yahoo.com
Abstract:   (162 Views)

Background and Objective: Breast cancer is a malignant lesion caused by abnormal changes and growth in breast tissue epithelial cells, including glands, lobules, and larynx. Therefore, the current study's objective was to estimate the incidence of breast and cervical intraepithelial lesions in Iran. This study is based on results from a screening program implemented in the province of Isfahan, Iran.
Methods: Two stages of cancer screening were performed in the study on over 250000 women in 2018.
Results: As a result of this study, it was determined that in 2018, there was an incidence of 422 benign breast tumors per 100 000 women (95% CI: 393-450). Also, the incidence of breast cancer was 65 (95% CI: 54-76) per 100 000 women, and that of Cervical intraepithelial lesions was 45 (95% CI: 27-63) per 100 000 women in 2018.
Conclusion: This study revealed that breast cancer and cervical intraepithelial lesions are increasing in Isfahan province. Moreover, it was found that screening for these 2 cancers leads to early detection of patients, which results in early treatment and an increase in the 5-year survival rate in these patients.

Full-Text [PDF 284 kb]   (13 Downloads) |   |   Full-Text (HTML)  (14 Views)  
Systematic Review: Original Research | Subject: Gynecology Oncology
Received: 2021/09/7 | Accepted: 2021/11/29 | Published: 2022/01/12

References
1. Ahmadnia Z, Joukar F, Hasavari F, Roushan ZA, Khalili M. Dietary Patterns and Risk of Breast Cancer in Women in Guilan Province, Iran. Asian Pac J Cancer Prev. 2016;17(4):2035-40. [DOI:10.7314/APJCP.2016.17.4.2035] [PMID]
2. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158-68. [DOI:10.1056/NEJMsa044278] [PMID]
3. Frumovitz M. Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis. UpToDate Available here[Accessed 30 May 2013]. 2011.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [DOI:10.3322/caac.21492] [PMID]
5. Rahimi M, Keyhani E, Behjati F. The Relation between Exon Variations of KIT Gene and Clinical Pathological Factors of Breast Cancer. J Obstet Gynecol Cancer Res. 2020;5(4):137-48. [DOI:10.30699/jogcr.5.4.137]
6. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364(9430):249-56. [DOI:10.1016/S0140-6736(04)16674-9]
7. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
8. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10-20. [DOI:10.7326/0003-4819-155-1-201107050-00003] [PMID] [PMCID]
9. Ahmadipour H, Sheikhizade S. Breast and Cervical Cancer Screening in Women Referred to Urban Healthcare Centers in Kerman, Iran, 2015. Asian Pac J Cancer Prev. 2016;17(S3):143-7. [DOI:10.7314/APJCP.2016.17.S3.143] [PMID]
10. Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, et al. Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer. PloS One. 2016;11(6):e0156705. [DOI:10.1371/journal.pone.0156705] [PMID] [PMCID]
11. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-35. [DOI:10.1001/jama.2014.1398] [PMID]
12. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health. 2000;114(2):143-5. [DOI:10.1016/S0033-3506(00)00324-3]
13. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24-7.
14. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461-84. [DOI:10.1016/S0140-6736(11)61351-2]
15. Enayatrad M, Amoori N, Salehiniya H. Epidemiology and trends in breast cancer mortality in iran. Iran J Public Health. 2015;44(3):430-1.
16. Mokarian F, Ramezani MA, Heydari K, Tabatabaeian M, Tavazohi H. Epidemiology and trend of cancer in Isfahan 2005-2010. J Res Med Sci. 2011;16(9):1228-33.
17. Tolou-Ghamari Z. Prevalence of Breast Cancer in Isfahan Province, Iran. J Womens Health. 2018(In Press). [DOI:10.5812/whb.82678]
18. Momenimovahed Z, Salehiniya H. Cervical cancer in Iran: integrative insights of epidemiological analysis. Biomedicine (Taipei). 2018;8(3):18. [DOI:10.1051/bmdcn/2018080318] [PMID] [PMCID]
19. Daroudi R, Akbari Sari A, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K. The Economic Burden of Breast Cancer in Iran. Iran J Public Health. 2015;44(9):1225-33.
20. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2(1):35. [DOI:10.1186/2046-4053-2-35] [PMID] [PMCID]
21. Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. JAMA. 2018;319(2):154-64. [DOI:10.1001/jama.2017.19130] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.